Hoersholm building 2


Novozymes and Chr. Hansen have joined forces to create Novonesis, a leading biosolutions partner. Working closely with our customers, we’re transforming the way the world produces, consumes and lives. 

To visit Novonesis.com, please click below:


Financial calendar

Novonesis will publish proforma numbers and outlook no later than March 31, 2024 and provide a Q1 trading statement on May 3, 2024. There won’t be a Q5 trading update for Chr. Hansen in February.

Company announcements and news

Share this with: